Functional characterization of cytochrome P4502B6 allelic variants

被引:123
作者
Jinno, H [1 ]
Tanaka-Kagawa, T [1 ]
Ohno, A [1 ]
Makino, Y [1 ]
Matsushima, E [1 ]
Hanioka, N [1 ]
Ando, M [1 ]
机构
[1] Natl Inst Hlth Sci, Div Environm Chem, Setagaya Ku, Tokyo 1588501, Japan
关键词
D O I
10.1124/dmd.31.4.398
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 (P450) 2B6 is a hepatic enzyme of potential importance for the metabolism of clinically used drugs and environmental or abused toxicants. Genetic polymorphisms of CYP2B6 (CYP2B6*2, CYP2B6*3, CYP2B6*4, CYP2B6*5, CYP2B6*6 and CYP2B6*7, wild-type, CYP2B6*1) were found previously in white and Japanese populations. In the present study, the goal was to investigate the effects of amino acid substitutions on CYP2B6 function. Wild-type (CYP2B6.1) and all of the known variants of CYP2B6 (CYP2B6.2, CYP2B6.3, CYP2B6.4, CYP2B6.5, CYP2B6.6, and CYP2B6.7) were transiently expressed in COS-1 cells, and their 7-ethoxy-4-trifluoromethylcoumarin O-deethylation activities were determined. The levels of the variant CYP2B6 proteins were relatively low compared with that of CYP2B6.1, although the differences were not significant. The activities of 7-ethoxy-4-trifluoromethylcoumarin O-deethylation on the basis of the CYP2B6 protein level at low (0.5 muM) and high (50 muM) substrate concentrations varied among wild-type and variant CYP2B6 proteins. All CYP2B6 enzymes showed typical Michaelis-Menten kinetics. The K-m value of CYP2B6.6 was significantly higher than that of CYP2B6.11. Those CYP2B6 variants having a Lys262Arg substitution (CYP2B6.4, CYP2B6.6, and CYP2B6.7) showed increased values for V-max and V-max/K-m, whereas the, kinetic parameters of CYP2B6.2 and CYP2B6.3 were not affected by the corresponding amino acid substitution. These results may mean that Lys262 in combination with other amino acid residues such as Gln172 and Arg487 is associated with the CYP2B6 function and that the genetic polymorphism of CYP2B6 leads to interindividual differences in xenobiotic metabolism.
引用
收藏
页码:398 / 403
页数:6
相关论文
共 39 条
[1]   5 OF 12 FORMS OF VACCINIA VIRUS-EXPRESSED HUMAN HEPATIC CYTOCHROME-P450 METABOLICALLY ACTIVATE AFLATOXIN-B1 [J].
AOYAMA, T ;
YAMANO, S ;
GUZELIAN, PS ;
GELBOIN, HV ;
GONZALEZ, FJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4790-4793
[2]   A single nucleotide polymorphism of CYP2B6 found in Japanese enhances catalytic activity by autoactivation [J].
Ariyoshi, N ;
Miyazaki, M ;
Toide, K ;
Sawamura, Y ;
Kamataki, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (05) :1256-1260
[3]   INDIVIDUAL VARIATION IN THE ACTIVATION AND INACTIVATION OF METABOLIC PATHWAYS OF CYCLOPHOSPHAMIDE [J].
BODDY, AV ;
FURTUN, Y ;
SARDAS, S ;
SARDAS, O ;
IDLE, JR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (22) :1744-1748
[4]  
CHANG TKH, 1993, CANCER RES, V53, P5629
[5]  
CHEN TL, 1995, CANCER RES, V55, P810
[6]  
Code EL, 1997, DRUG METAB DISPOS, V25, P985
[7]   Engineering microsomal cytochrome P4502C5 to be a soluble, monomeric enzyme - Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding [J].
Cosme, J ;
Johnson, EF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2545-2553
[8]  
Dai D, 2001, J PHARMACOL EXP THER, V299, P825
[9]   Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes [J].
Daly, AK ;
Fairbrother, KS ;
Smart, J .
TOXICOLOGY LETTERS, 1998, 103 :143-147
[10]   The role of CYP2B6 in human xenobiotic metabolism [J].
Ekins, S ;
Wrighton, SA .
DRUG METABOLISM REVIEWS, 1999, 31 (03) :719-754